Treatment for aristolochic acid nephropathy with integrated liposomal prostaglandin E_1 and calcium dobesilate.
- VernacularTitle:前列腺素E_1和羟苯磺酸钙联合应用对马兜铃酸肾病临床疗效分析
- Author:
Yanqiu LI
;
Qiuling FAN
;
Li YAO
- Publication Type:Journal Article
- Keywords:
Aristolochic acid nephropathy;
Liposomal prostaglandin E_1;
Calcium dobesilate
- From:
Chinese Journal of Practical Internal Medicine
2000;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effects of integrated liposomal prostaglandin E_1(PGE_1)and calcium dobesilate on aristolochic acid nephropathy(AAN).Methods Forty-six patients of AAN who came from the First Affiliated Hospital,China Medical University from 2003 to 2005 were randomly divided into control group(PGE_1)and treatment group(PGE_1+calcium dobesilate).Scr and Hb were compared between two groups before and after the treatment.Results Scr had been decreased significantly and Hb had been increased in both groups,but more significantly in treatment group than in control group.Conclusion Integrated liposomal prostaglandin E_1 and calcium dobesilate can ameliorate renal function in AAN.
